Invasive Mould Infection
1 clinical trials · Condition
◉ Watch Invasive Mould Infection
| Record | Firm | Date |
|---|---|---|
| Phase 2 EL219 Versus Liposomal Amphotericin B or Voriconazole for Early Antifungal Therapy (NCT07215273) | Elion Therapeutics, Inc. | 2026-02-13 |
Track Invasive Mould Infection automatically
Every clearance here is in the API, with alerts when new ones post.